Project Grant R16GM165524
- The National Institute of General Medical Sciences awarded The Research Foundation For The State University of New York $434,892 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support structural and biosynthetic research on natural product enzymes. The award funds investigation of nonribosomal peptide synthetases (NRPSs) and NRPS-independent siderophore biosynthetic pathways, with focus on the conformational dynamics that NRPSs employ to...
- The National Institute of General Medical Sciences awarded the University of Rochester $427,227 on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the molecular mechanisms of gene-regulatory RNA molecules called riboswitches. The funded research uses high-resolution structural approaches and in-cell methods to elucidate how riboswitches sense metabolites and ions through conformational changes that control downstream gene expression. The...
- The National Institute of General Medical Sciences awarded The Research Foundation For The State University Of New York (Stony Brook University) $432,569 on March 5, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the regulatory mechanisms of extracellular particle-mediated intercellular signaling. The research deciphers how cells release extracellular particles containing biomolecules to establish non-contact communication with neighboring or...
- The National Institute of General Medical Sciences awarded The Wistar Institute of Anatomy and Biology $506,550 on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research on compartmentalization and discrimination of double-stranded RNA in the nucleus. The funded research explores fundamental biological principles governing how cells distinguish self from non-self RNA molecules, specifically examining the balance between sensing pathogenic...
- The National Institute of General Medical Sciences awarded The Research Foundation For The State University Of New York $896,502 on May 20, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing Project Grant) to conduct research on RNA polymerase I biogenesis and transcription regulation. The project investigates the molecular mechanisms governing assembly of the multi-subunit RNA polymerase I complex, the role of POL I subunits in driving...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $1,048,299 to The Research Foundation For The State University Of New York (RF-SUNY) on August 1, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to acquire a LUMICKS C-TRAP Correlative Force and Fluorescence Optical Tweezer System for the RNA Institute at the University at Albany. This instrument enables real-time observation, monitoring, and quantification of...
- The National Institute of General Medical Sciences awarded The Research Foundation for the State University of New York $343,007 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to characterize glycosylation regulatory networks using single-cell multiomics and mathematical modeling. The project generates single-cell epigenomics, transcriptomics, and glycomics profiles during hematopoietic stem cell differentiation to identify key regulators and...
- The National Institute of General Medical Sciences awarded Icahn School of Medicine at Mount Sinai $462,000 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to advance spatial imaging frameworks that reveal how non-coding RNAs organize within the nucleus across developmental and environmental contexts. The research establishes three interconnected themes. Theme 1 extends RNA MERFISH to profile small non-coding RNAs by incorporating enzymatic...
- The National Institute of General Medical Sciences awarded the University of Rochester $578,733 on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to elucidate the biological roles of tRNA modification enzymes. The award funds research combining biochemistry, molecular biology, and genetics to resolve knowledge gaps about how tRNA modifications impact tRNA structure and function, the roles of vertebrate-specific tRNA modification enzymes, and how these...
- The National Institute of General Medical Sciences awarded The Research Foundation for the State University of New York $432,844 on July 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing) to fund development and application of dynamic, cell-instructive biomaterials that model mechanical regulation of macrophages in inflammation, tissue repair, fibrosis, and cancer. The award supports three integrated research innovations: curvature platforms...
The National Institute of General Medical Sciences, National Institutes of Health, awarded The Research Foundation For The State University Of New York $191,000 on August 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to quantify RNA base-stacking energetics and their functional consequences under physiologically relevant conditions. The recipient will conduct systematic measurements of stacking energies across all 16 RNA base-stack combinations using a high-throughput single-molecule force-clamp assay. Work encompasses three primary aims: quantifying stacking energies for each base-stack pair, determining how stacking is modulated by temperature, ionic composition, and molecular crowding, and evaluating the functional consequences of stacking in RNA ligation and strand displacement reactions. The research addresses a gap in mechanistic understanding of RNA structure, stability, and function by providing experimentally validated parameters for force-field refinement, enhancing predictive modeling of RNA folding, and linking stacking energetics to RNA-mediated processes including strand exchange, frameshifting, RNA condensation, and riboswitch function. Performance occurs in New Paltz, New York. The period of performance runs from August 10, 2026, through March 31, 2030. This is a Project Grant, a category of assistance under NIGMS's basic research portfolio supporting fundamental discoveries that advance understanding of human health and disease.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $191.0k | 8/7/26 |